Inflammatory and fibrotic mediator release by alveolar macrophages from coal miners
- 1 September 1995
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health
- Vol. 46 (1) , 9-21
- https://doi.org/10.1080/15287399509532014
Abstract
Eicosanoids and cytokines produced by alveolar macrophages (AM) are key mediators of pulmonary inflammation and fibrosis. In order to determine if eicosanoid production and cytokine production are altered in AM obtained from coal miners, we compared production of prostaglandin E2 (PGE2), thromboxane A2 (TXA2), leukotriene B4 (LTB4), interleukin‐1 beta (IL‐1β), and tumor necrosis factor alpha (TNFα) by cultured AM from normal human subjects and coal miners. The recovery of AM from miners’ lungs by bronchoalveolar lavage was significantly greater than that from control subjects. Mean eicosanoid and cytokine production by AM from active miners was also increased compared to AM from control subjects, but this increase was not statistically significant. AM from control subjects produced significantly more TXA2 and TNFα when exposed to lipopolysaccharide than did AM from miners. The cyclooxygenase inhibitor suprofen reduced PGE2 and TXA2 production and TNFα release but had no effect on LTB4 production or IL‐1β release by miners’ AM. The lipoxygenase inhibitor nordihydroguaiaretic acid attenuated TNFα release, as well as that of LTB4, but had no effect on IL‐1β release. Inhibition of thromboxane synthase by UK 38,485 also reduced TNFα release by active miners’ AM but had no effect on PGE2, LTB4 production, or IL‐1β release. The results of these studies suggest that occupational inhalation of coal dust may increase total lung eicosanoid and cytokine levels and reduce the reactivity of AM to bacterial endotoxin. Furthermore, coal dust‐induced changes in both eicosanoid and cytokine release may be subject to pharmacological modulation.Keywords
This publication has 22 references indexed in Scilit:
- An inhibitor of thromboxane production attenuates tumor necrosis factor release by activated human alveolar macrophagesProstaglandins, 1993
- TNF and other cytokines in the metabolism of septic shock and cachexiaClinical Nutrition, 1992
- Mechanisms of pulmonary edema induced by tumor necrosis factor-alpha.Circulation Research, 1990
- Effect of in vivo coal dust exposure on arachidonic acid metabolism in the rat alveolar macrophageJournal of Toxicology and Environmental Health, 1990
- Indomethacin stimulation of macrophage cytostasis against MOPC-315 tumor cells is enhanced by endogenous metabolites of lipoxygenase and counteracted by prostaglandin E2Inflammation Research, 1989
- Regulation of macrophage tumor necrosis factor production by prostaglandin E2Biochemical and Biophysical Research Communications, 1986
- Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis.Journal of Clinical Investigation, 1984
- Resting macrophages produce distinct metabolites from exogenous arachidonic acidThe Journal of Experimental Medicine, 1982
- Effects of cyclooxygenase inhibitors and prostaglandin E2 on macrophage activation in vitroProstaglandins, 1981
- Stimulation of oxidant production in alveolar macrophages by pollutant and latex particlesEnvironmental Research, 1980